Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
PB Ratio: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-book ratio
Latest
1.28
↓ 61% below average
Average (9y)
3.31
Historical baseline
Range
High:12.15
Low:1.15
CAGR
-22.1%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.28 | -56.8% |
| 2023 | 2.97 | +9.6% |
| 2022 | 2.71 | -38.0% |
| 2021 | 4.37 | +59.2% |
| 2020 | 2.75 | +139.4% |
| 2019 | 1.15 | -6.8% |
| 2018 | 1.23 | -18.7% |
| 2017 | 1.51 | -49.2% |
| 2016 | 2.98 | -75.5% |
| 2015 | 12.15 | - |